Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A1P3 stands for solute carrier family 25 member 1 pseudogene 3. This locus is classified as a pseudogene, which means it is a segment of DNA that resembles a functional gene (in this case, likely related to the mitochondrial citrate transporter protein SLC25A1), but it is not functional and does not produce a functional protein. Pseudogenes like SLC25A1P3 may arise via gene duplication or retrotransposition and typically accumulate mutations that prevent protein coding. Some pseudogenes can exert regulatory roles at the RNA level, potentially affecting gene expression or cellular function by acting as RNA decoys or competing for regulatory factors, but there is no evidence that SLC25A1P3 has a defined biological function of this type. SLC25A1P3 is not considered a therapeutic target, and there are no drugs or biomarkers associated with it.
Not applicable. Pseudogenes are generally not drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 1 pseudogene 3 (SLC25A1P3).